project id: TCGA-KIRP; case submitter id: TCGA-2Z-A9J7; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.96; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.57; rna integrity number: 8.9; age at index: 63; days to birth: -23230; days to death: 139; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1944; year of death: 2007; age at diagnosis: 23230; ajcc clinical m: M1; ajcc clinical n: N0; ajcc clinical stage: Stage IV; ajcc clinical t: T2; ajcc pathologic m: M1; ajcc pathologic n: NX; ajcc pathologic stage: Stage IV; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C64.1; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2007; alcohol history: Not Reported; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; years smoked: 21.0; is ffpe: false; composition: Not Reported; days to collection: 2524; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-2Z-A9J7-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 2.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 3.0; percent tumor cells: 95.0; percent tumor nuclei: 95.0;